IRADIMED CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 41.86 USD | +0.94% |
|
+2.10% | -11.82% |
| Apr. 03 | IRadimed Files $75 Million Common Stock Shelf Registration | MT |
| Feb. 08 | Transcript : IRadimed Corporation, Q4 2023 Earnings Call, Feb 08, 2024 |
Presentation Operator MessageOperator (Operator)Welcome to the IRadimed Corporation Fourth Qua...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
IRadimed Corporation develops, manufactures, markets and distributes magnetic resonance imaging (MRI) compatible medical devices and accessories and services. Its MRidium 3860+ MRI Compatible IV infusion pump system provides non-magnetic Intravenous (IV) infusion pump system that is specifically designed for safe use during MRI procedures. Its MRidium MRI compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor with non-ferrous parts and other special features to deliver anesthesia safely and predictably and other IV medications or fluids during various MRI procedures. Its IRadimed 3880 MRI Compatible patient vital signs monitoring system has been designed with non-magnetic components and other features to monitor a patientâs vital signs safely and accurately during various MRI procedures. The Company sells its products primarily to hospitals and acute care facilities. The IRADIMED 3880 system operates dependably in magnetic fields up to 30,000 gausses.
Calendar
2024-05-01
- Q1 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
D+
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
41.86
USD
Average target price
62.5
USD
Spread / Average Target
+49.31%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -11.82% | 530M | |
| +73.17% | 12.38B | |
| -18.74% | 7.92B | |
| +16.15% | 7.2B | |
| +4.81% | 5.84B | |
| +5.99% | 5.07B | |
| +27.07% | 4.53B | |
| -21.67% | 3.88B | |
| -40.82% | 2.23B | |
| +1.49% | 2.02B |
- Stock Market
- Equities
- IRMD Stock
- News IRADIMED CORPORATION
- Transcript : IRadimed Corporation, Q4 2023 Earnings Call, Feb 08, 2024
